Definitive Healthcare Corp. (NASDAQ:DH) Short Interest Down 9.2% in November

Definitive Healthcare Corp. (NASDAQ:DH) saw a significant drop in short interest in November. As of November 30th, there was short interest totalling 2,460,000 shares, a drop of 9.2% from the November 15th total of 2,710,000 shares. Approximately 5.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 425,400 shares, the days-to-cover ratio is presently 5.8 days.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on DH. BTIG Research started coverage on Definitive Healthcare in a research report on Tuesday, September 17th. They set a “buy” rating and a $7.00 target price for the company. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research report on Friday, November 8th. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $5.81.

Insider Activity

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the company’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the transaction, the insider now owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This represents a 9.40 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.84% of the stock is currently owned by corporate insiders.

Institutional Trading of Definitive Healthcare

Large investors have recently bought and sold shares of the business. Point72 DIFC Ltd boosted its position in Definitive Healthcare by 759.9% during the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after acquiring an additional 8,215 shares during the last quarter. Intech Investment Management LLC acquired a new position in shares of Definitive Healthcare during the 3rd quarter worth about $55,000. Bleakley Financial Group LLC acquired a new stake in shares of Definitive Healthcare in the third quarter valued at approximately $74,000. Glenmede Trust Co. NA lifted its holdings in Definitive Healthcare by 41.1% during the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock valued at $82,000 after purchasing an additional 5,362 shares during the last quarter. Finally, SG Americas Securities LLC bought a new stake in shares of Definitive Healthcare during the 3rd quarter worth about $84,000. 98.67% of the stock is owned by institutional investors.

Definitive Healthcare Stock Performance

NASDAQ:DH remained flat at $4.46 during trading hours on Tuesday. 306,224 shares of the company’s stock traded hands, compared to its average volume of 717,595. The stock has a market cap of $515.23 million, a P/E ratio of -1.42, a price-to-earnings-growth ratio of 3.29 and a beta of 1.40. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The firm has a 50 day moving average price of $4.41 and a 200 day moving average price of $4.71. Definitive Healthcare has a 1 year low of $3.19 and a 1 year high of $10.62.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.